4//SEC Filing
STEMLINE THERAPEUTICS INC 4
Accession 0001104659-17-040454
CIK 0001264587operating
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 5:17 PM ET
Size
7.1 KB
Accession
0001104659-17-040454
Insider Transaction Report
Form 4
ZUERBLIS KENNETH J
Director
Transactions
- Award
Stock Options (right to buy)
2017-06-19+24,000→ 24,000 totalExercise: $8.20From: 2018-06-19Exp: 2027-06-19→ Common Stock (24,000 underlying) - Award
Common Stock
2017-06-19+10,000→ 31,963 total
Footnotes (3)
- [F1]The restricted shares will vest according to the following schedule: 3,334 shares on 6/19/2018, 3,333 shares on 6/19/2019 and 3,333 shares on 6/19/2020.
- [F2]Of the 31,963 shares, 16,666 shares are restricted stock.
- [F3]The options will vest according to the following schedule: one-third on each of 6/19/2018, 6/19/2019, and 6/19/2020.
Documents
Issuer
STEMLINE THERAPEUTICS INC
CIK 0001264587
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001264587
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 5:17 PM ET
- Size
- 7.1 KB